𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

✍ Scribed by Dr Fernanda Rosa, Andreas Schreiner, Pierre Thomas, Tarek Sherif

Book ID
119931399
Publisher
Springer International Publishing AG
Year
2012
Tongue
English
Weight
157 KB
Volume
32
Category
Article
ISSN
1179-1918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Switching stable patients with schizophr
Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
✍ Chris Hawley; Martin Turner; Muhammud A Latif; Vivienne Curtis; Packeruther T Sa πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 171 KB πŸ‘ 2 views

## Abstract ## Objective An international, non‐randomised study evaluated efficacy and safety of risperidone long‐acting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method

Remission in schizophrenia: one-year Ita
Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder
✍ Alessandro Rossi; Anna BagalΓ ; Vincenzo Del Curatolo; Francesco Scapati; Micaela πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac